A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
A phase 2/3 trial of Pivekimab sunirine, Venetoclax and Azacitidine in acute myeloid leukaemia, run by AbbVie, now recruiting.
Overview
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) is a phase 2/3 interventional study registered as NCT07581002 by AbbVie, with 660 participants planned, started 2026-06-30 and due to reach its primary completion in 2032-06. Interventions recorded: Pivekimab Sunirine, Venetoclax, Azacitidine and Matching Placebo for PVEK.
Similar pages
not linked directly; found by shared links- TrialIMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia
Shares Pivekimab sunirine, Azacitidine, AbbVie (incl. ImmunoGen, Capstan), Venetoclax and the tag pipeline.
- TrialA Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.
- TrialStudy of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
Shares Pivekimab sunirine, AbbVie (incl. ImmunoGen, Capstan) and the tag pipeline.
- TrialA Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.
- TrialStudy of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.
- TrialA Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Shares AbbVie (incl. ImmunoGen, Capstan), Venetoclax and the tag pipeline.
- TrialA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.
- TrialStudy to Evaluate the Safety and Tolerability of EP0042
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.